The Lancet Neurology
Publisher: Elsevier · ISSN 1474-4422 · 41 articles
- APOE, p-tau217, and cognitive impairment in diverse cohorts
- From syndrome to antibody-defined autoimmune encephalitides
- Staged bilateral focused ultrasound pallidothalamic tractotomy for Parkinson's disease
- Staged bilateral focused ultrasound pallidothalamic tractotomy for Parkinson's disease – Authors' reply
- Katrin Andreasson: rethinking neurodegeneration
- Safety and efficacy of delpacibart zotadirsen in Duchenne muscular dystrophy mutations amenable to exon 44 skipping in the USA (EXPLORE44): a randomised, placebo-controlled, double-blind, phase 1/2 trial
- Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study
- Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies
- Reframing traumatic brain injury and spinal cord injury as chronic multisystem disorders: toward integrated, long-term care
- Antibody-mediated encephalitides: distinct diseases with transdisciplinary implications
- Safety, tolerability, and efficacy of bepranemab in people living with prodromal-to-mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2 trial